Cargando…
Engineering Next-Generation BET-Independent MLV Vectors for Safer Gene Therapy
Retroviral vectors have shown their curative potential in clinical trials correcting monogenetic disorders. However, therapeutic benefits were compromised due to vector-induced dysregulation of cellular genes and leukemia development in a subset of patients. Bromodomain and extraterminal domain (BET...
Autores principales: | El Ashkar, Sara, Van Looveren, Dominique, Schenk, Franziska, Vranckx, Lenard S., Demeulemeester, Jonas, De Rijck, Jan, Debyser, Zeger, Modlich, Ute, Gijsbers, Rik |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Society of Gene & Cell Therapy
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5415309/ https://www.ncbi.nlm.nih.gov/pubmed/28624199 http://dx.doi.org/10.1016/j.omtn.2017.04.002 |
Ejemplares similares
-
BET-independent MLV-based Vectors Target Away From Promoters and Regulatory Elements
por: El Ashkar, Sara, et al.
Publicado: (2014) -
Towards a Safer, More Randomized Lentiviral Vector Integration Profile Exploring Artificial LEDGF Chimeras
por: Vranckx, Lenard S., et al.
Publicado: (2016) -
Improved functionality and potency of next generation BinMLV viral vectors toward safer gene therapy
por: Van Looveren, Dominique, et al.
Publicado: (2021) -
Targeted editing of the PSIP1 gene encoding LEDGF/p75 protects cells against HIV infection
por: Lampi, Yulia, et al.
Publicado: (2019) -
Retroviral integration: Site matters: Mechanisms and consequences of retroviral integration site selection
por: Demeulemeester, Jonas, et al.
Publicado: (2015)